Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor
Background Most adoptive cell therapies (ACTs) suffer from an inability to control the therapeutic cell’s behavior following its transplantation into a patient. Thus, efforts to inhibit, activate, differentiate or terminate an ACT after patient reinfusion can be futile, because the required drug adv...
Saved in:
| Main Authors: | Xin Liu, Boning Zhang, John Victor Napoleon, Qian Luo, Madduri Srinivasarao, Philip S Low |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000756.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01) -
Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation
by: Shaomei Feng, et al.
Published: (2025-06-01) -
Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapy
by: C. Carcopino, et al.
Published: (2024-12-01) -
Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T‐Cell Therapy
by: Jia Yi Tan, et al.
Published: (2025-03-01) -
Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.
by: Minsung Kim, et al.
Published: (2018-01-01)